from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1669/-

LFCtreatmentdescriptionclass of inhibitor

0.329

Amikacinug/mL Amikacintranslation

-0.384

Cap5-10ug/mL Capreomycintranslation

-0.108

Rox10-50 ug/mL Roxithromycintranslation

-0.656

SM2-5 ug/mL Streptomycintranslation

0.645

Tet5-10 ug/mL Tetracyclinetranslation

1.348

Rif0.2-5ug/mL Rifampicintranscription

1.788

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.935

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.341

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.322

CPZ10-50 ug/mL Chlorpromazinerespiration

0.248

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.549

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.988

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.686

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.153

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.426

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.414

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.474

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.828

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.009

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.663

KCN5-20 ug/mL Potassium cyaniderespiration

0.017

NaN30.2-2 mM Sodium aziderespiration

-0.892

Nigericin50 uM Nigericinrespiration

0.877

TRC10-150 ug/mL Triclosanrespiration

1.203

TRZ10-25 ug/mL Thioridazinerespiration

0.562

Valinomycin0.5-10 uM Valinomycinrespiration

-1.760

ZnSO42 mM ZnSO4respiration

-0.000

menadione6-10 ug/mL Menadionerespiration

0.369

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.641

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.274

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.612

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.324

NRP_1Non-replicating persistence stage 1dosRassociated

-0.714

Amp0.2mg/mL AmpicillincellWall

-0.565

Cephalexin20-100 ug/mL CephalexincellWall

0.331

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.331

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.204

EMB10-20 ug/mL EthambutolcellWall

-0.735

Eta12-40 ug/mL EthionamidecellWall

-0.851

INH0.2-0.4 ug/mL IsoniazidcellWall

0.367

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.430

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.063

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.121

BZA0.12 mg/mL BenzamidearomaticAmides

-0.348

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.635

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.315

H2O24 mM hydrogen peroxideDNAdamaging

-0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.688

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.671

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.038

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.226

UVUV-irradiationDNAdamaging

1.537

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.163

Antimycin12.5-50 ug/mL Antimycin A?

-0.052

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.372

PA_110-50 ug/mL Antitubercular compound PA-1?

0.355

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.543

PA8240.2-2 ug/mL PA-824?

0.219

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.101

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.717

Verapamil50 uM Verapamil?

0.683

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.667

methoxatin10-20 ug/mL Methoxatin?